Comparing Radiological Tubal Blockage Versus Laparoscopic Salpingectomy in Infertile Women With Hydrosalpinx During in Vitro Fertilization Treatment
- Conditions
- IVF-ETHydrosalpinx
- Interventions
- Procedure: laparoscopic salpingectomyProcedure: radiological tubal blockage
- Registration Number
- NCT03521128
- Lead Sponsor
- ShangHai Ji Ai Genetics & IVF Institute
- Brief Summary
Hydrosalpinx (HX) has a detrimental effect on the rates of implantation, pregnancy, live delivery, and early pregnancy loss during in vitro fertilization (IVF). The effectiveness of radiological tubal blockage has not been compared with the standard treatment of laparoscopic salpingectomy in randomized trials. The investigators aim in this randomized trial to compare the live birth rate of radiological tubal blockage versus laparoscopic salpingectomy in infertility women with HX prior to frozen-thawed embryo transfer (FET). Eligible women will be recruited and randomized into one of the following two groups: (1) the radiological tubal blockage group and (2) the laparoscopic salpingectomy group. The primary outcome is the live birth rate.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- Female
- Target Recruitment
- Not specified
- Women aged 20-43 years at the time of IVF/ICSI treatment
- Unilateral or bilateral HX visible on pelvic ultrasound or hysterosalpingogram
- At least one frozen embryo or blastocyst available for transfer
- A history of pelvic inflammatory disease within 6 months
- HX that were already blocked proximally on hysterosalpingogram
- Frozen pelvis from previous laparoscopy
- Women with fibroids interfering with radiological tubal blockage
- Undergoing preimplantation genetic testing
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description the laparoscopic salpingectomy group laparoscopic salpingectomy - the radiological tubal blockage group radiological tubal blockage -
- Primary Outcome Measures
Name Time Method live birth rate a live birth after 22 weeks gestation, through study completion, an average of 1 year the rate of live births per cycle
- Secondary Outcome Measures
Name Time Method ectopic pregnancy ectopic pregnancy during first trimester, up to 12 weeks pregnancy outside the uterine cavity
birth weight a live birth after 22 weeks gestation, through study completion, an average of 1 year birth weight of the baby delivered
implantation rate number of gestational sacs per embryo transferred at 6 weeks of pregnancy, up to 6 weeks number of gestational sacs per embryo transferred
multiple pregnancy multiple pregnancy beyond gestation 12 weeks up to 12 weeks more than one intrauterine sacs on scanning
clinical pregnancy rate presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy, up to 6 weeks presence of intrauterine gestational sac on ultrasound at 6 weeks of pregnancy
positive hCG level A blood hCG test is performed 14 days after the FET, up to 14 days defined with the result of serum β-hCG ≥10 mIU/mL.
ongoing pregnancy rate iable pregnancy beyond gestation 12 weeks, up to 12 weeks presence of a fetal pole with pulsation at 12 weeks of gestation
miscarriage rate a clinically recognized pregnancy loss before the 22 weeks of pregnancy, up to 22 weeks defined as a clinically recognized pregnancy loss before the 22 weeks of pregnancy. The denominator is the clinical pregnancy.
Trial Locations
- Locations (1)
ShangHai JIAI Genetics&IVF Institute
🇨🇳Shanghai, China